These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 6359412)
1. [Description of cytochrome p-450 research]. Wang XL Sheng Li Ke Xue Jin Zhan; 1983 Jul; 14(3):233-7. PubMed ID: 6359412 [No Abstract] [Full Text] [Related]
2. [Cytochrome P-450: the effect of drugs and poisons]. Chekman IS; Grinevich AI Farmakol Toksikol; 1984; 47(1):119-23. PubMed ID: 6705899 [No Abstract] [Full Text] [Related]
3. Mechanisms of the inhibition of cytochrome P-450-mediated drug oxidation by therapeutic agents. Murray M Drug Metab Rev; 1987; 18(1):55-81. PubMed ID: 3311684 [No Abstract] [Full Text] [Related]
4. Human cytochrome P450: possible roles of drug-metabolizing enzymes and polymorphic drug oxidation in addiction. Gonzalez FJ NIDA Res Monogr; 1991; 111():202-13. PubMed ID: 1775182 [No Abstract] [Full Text] [Related]
5. Failure in drug development: the role of inhibition and induction of cytochrome P450 enzymes. Hengstler JG; Bolt HM Arch Toxicol; 2008 Oct; 82(10):665-6. PubMed ID: 18751968 [No Abstract] [Full Text] [Related]
7. Reductive-oxygenation mechanism of metabolism of carbon tetrachloride to phosgene by cytochrome P-450. Pohl LR; Schulick RD; Highet RJ; George JW Mol Pharmacol; 1984 Mar; 25(2):318-21. PubMed ID: 6700577 [TBL] [Abstract][Full Text] [Related]
8. The characterization of an inhibitory complex formed with cytochrome P-450 and a metabolite of 1,1-disubstituted hydrazines. Hines RN; Prough RA J Pharmacol Exp Ther; 1980 Jul; 214(1):80-6. PubMed ID: 7391974 [No Abstract] [Full Text] [Related]
9. Isoflurane enhances dechlorination of carbon tetrachloride in guinea-pig liver microsomes. Fujii K; Rahman MM; Yuge O J Appl Toxicol; 1996; 16(3):249-53. PubMed ID: 8818866 [TBL] [Abstract][Full Text] [Related]
10. Induction of cytochrome P4501 as an indicator of potential chemical carcinogenesis. Ioannides C; Parke DV Drug Metab Rev; 1993; 25(4):485-501. PubMed ID: 8313839 [No Abstract] [Full Text] [Related]
11. [Features of the metabolism of various drugs involving cytochrome P-450 isoenzymes]. Filimonova AA; Ziganshin AU; Ziganshina LE Eksp Klin Farmakol; 2007; 70(3):69-77. PubMed ID: 17650639 [TBL] [Abstract][Full Text] [Related]
13. Induction of drug metabolism: species differences and toxicological relevance. Graham MJ; Lake BG Toxicology; 2008 Dec; 254(3):184-91. PubMed ID: 18824059 [TBL] [Abstract][Full Text] [Related]
14. [Clinico-pharmacological aspects of enzyme induction]. Bartłomowicz B Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1430-3. PubMed ID: 3913943 [No Abstract] [Full Text] [Related]
15. Drug interactions with cytochrome P-450. Mege J Pa Med; 1998 Sep; 101(9):16-7. PubMed ID: 9782709 [No Abstract] [Full Text] [Related]
16. Clinical implications of genetic polymorphisms and drug interactions mediated by cytochrome P-450 enzymes. Touw DJ Drug Metabol Drug Interact; 1997; 14(2):55-82. PubMed ID: 9893738 [TBL] [Abstract][Full Text] [Related]
17. How the pharmacogenetics of cytochrome P450 enzymes may affect prescribing. Roberts RL; Begg EJ; Joyce PR; Kennedy MA N Z Med J; 2002 Mar; 115(1150):137-40. PubMed ID: 12013308 [No Abstract] [Full Text] [Related]
18. Renal drug metabolism. Lohr JW; Willsky GR; Acara MA Pharmacol Rev; 1998 Mar; 50(1):107-41. PubMed ID: 9549760 [No Abstract] [Full Text] [Related]